These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8387573)

  • 1. Efficacy of oral 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the treatment of retrovirus and cytomegalovirus infections in mice.
    Naesens L; Neyts J; Balzarini J; Holy A; Rosenberg I; De Clercq E
    J Med Virol; 1993 Feb; 39(2):167-72. PubMed ID: 8387573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the prophylaxis of retrovirus infection in vivo.
    Naesens L; Balzarini J; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):53-64. PubMed ID: 1776876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of the anti-HIV agent 9-(2-phosphonyl-methoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivo.
    Neyts J; Stals F; Bruggeman C; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):437-46. PubMed ID: 8395382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): a novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-Moloney murine sarcoma virus activity in vivo.
    Naesens L; Balzarini J; Rosenberg I; Holý A; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1043-7. PubMed ID: 2559845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
    Naesens L; Balzarini J; Bischofberger N; De Clercq E
    Antimicrob Agents Chemother; 1996 Jan; 40(1):22-8. PubMed ID: 8787873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9-(2-Phosphonylmethoxyethyl)-N6-cyclopropyl-2,6-diaminopurine (cpr-PMEDAP) as a prodrug of 9-(2-phosphonylmethoxyethyl)guanine (PMEG).
    Compton ML; Toole JJ; Paborsky LR
    Biochem Pharmacol; 1999 Aug; 58(4):709-14. PubMed ID: 10413310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine.
    Balzarini J; Holy A; Jindrich J; Naesens L; Snoeck R; Schols D; De Clercq E
    Antimicrob Agents Chemother; 1993 Feb; 37(2):332-8. PubMed ID: 8452366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-retrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in vivo increases when it is less frequently administered.
    Balzarini J; Naesens L; De Clercq E
    Int J Cancer; 1990 Aug; 46(2):337-40. PubMed ID: 2384280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of 9-(2-phosphonylmethoxyethyl)adenine and 3'-azido-2',3'-dideoxythymidine on tumor development in mice inoculated intracerebrally with Moloney murine sarcoma virus.
    Balzarini J; Sobis H; Naesens L; Vandeputte M; De Clercq E
    Int J Cancer; 1990 Mar; 45(3):486-9. PubMed ID: 2307539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-cyclopropyl-PMEDAP: a novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties.
    Hatse S; Naesens L; De Clercq E; Balzarini J
    Biochem Pharmacol; 1999 Jul; 58(2):311-23. PubMed ID: 10423173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 9-(2-phosphonylmethoxyethyl)-N6-cyclopropyl-2,6-diaminopurine: a novel prodrug of 9-(2-phosphonylmethoxyethyl)guanine with improved antitumor efficacy and selectivity in choriocarcinoma-bearing rats.
    Naesens L; Hatse S; Segers C; Verbeken E; De Clercq E; Waer M; Balzarini J
    Oncol Res; 1999; 11(4):195-203. PubMed ID: 10566618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo.
    De Clercq E; Holý A; Rosenberg I
    Antimicrob Agents Chemother; 1989 Feb; 33(2):185-91. PubMed ID: 2719463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent.
    Balzarini J; Naesens L; Herdewijn P; Rosenberg I; Holy A; Pauwels R; Baba M; Johns DG; De Clercq E
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):332-6. PubMed ID: 2911579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
    Rossi L; Dominici S; Serafini S; Casabianca A; Cerasi A; Chiarantini L; Celeste AG; Cappellacci L; Franchetti P; Grifantini M; Magnani M
    J Antimicrob Chemother; 2002 Sep; 50(3):365-74. PubMed ID: 12205061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of BMS-180194 against experimental cytomegalovirus infections in immunocompromised mice.
    Yang H; Drain RL; Franco CA; Clark JM
    Antiviral Res; 1996 Mar; 29(2-3):233-41. PubMed ID: 8739602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo.
    Balzarini J; Holy A; Jindrich J; Dvorakova H; Hao Z; Snoeck R; Herdewijn P; Johns DG; De Clercq E
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4961-5. PubMed ID: 1711214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of novel purine acyclic nucleotide analogs PMEA and PMEDAP.
    Otová B; Zídek Z; Holý A; Votruba I; Sladká M; Marinov I; Lesková V
    In Vivo; 1997; 11(2):163-7. PubMed ID: 9179610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo inhibition of murine leukemia and sarcoma viruses by the heteropolyanion 5-tungsto-2-antimoniate.
    Jasmin C; Chermann JC; Herve G; Teze A; Souchay P; Boy-Loustau C; Raybaud N; Sinoussi F; Raynaud M
    J Natl Cancer Inst; 1974 Aug; 53(2):469-74. PubMed ID: 4367244
    [No Abstract]   [Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses.
    Hakimelahi GH; Ly TW; Moosavi-Movahedi AA; Jain ML; Zakerinia M; Davari H; Mei HC; Sambaiah T; Moshfegh AA; Hakimelahi S
    J Med Chem; 2001 Oct; 44(22):3710-20. PubMed ID: 11606136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.